You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Biliary Tract Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Biliary Tract Cancer Trial (H101, Tislelizumab, Lenvatinib)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • (no location specified)
Apr 11, 2023

Advanced Biliary Tract Cancer Trial in Tianjin (Cadonilimab+Regorafenib+GC)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Apr 7, 2023

Advanced Biliary Tract Cancer Trial (anlotinib+TQB2450+nab-paclitaxel+cisplatin)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • (no location specified)
Apr 2, 2023

Advanced Biliary Tract Cancer Trial in Shanghai (Sintilimab, Lenvatinib, Cryoablation)

Recruiting
  • Advanced Biliary Tract Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 22, 2023

Biliary Tract Tumors, Immunotherapy Trial in Beijing (Durvalumab, Lenvatinib Oral Product, Chemotherapy)

Recruiting
  • Biliary Tract Neoplasms
  • Immunotherapy
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Jul 6, 2023

Advanced Biliary Tract Cancer Trial in Changsha (IBI310, sintilimab)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • Changsha, Hunan, China
    Hunan cancer Hospital
Dec 13, 2022

Locally Advanced Biliary Tract Cancer, Metastatic Biliary Tract Cancer Trial in Guangzhou (Camrelizumab and Apatinib Plus GP)

Not yet recruiting
  • Locally Advanced Biliary Tract Cancer
  • Metastatic Biliary Tract Cancer
  • Camrelizumab and Apatinib Plus GP
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Feb 15, 2023

Biliary Tract Cancer, Immune Checkpoint Inhibitor, Predictive Cancer Model Trial in Beijing (Immune Checkpoint Inhibitors)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Immune Checkpoint Inhibitors
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Oct 5, 2023

Biliary Tract Cancer, Candonilimab, Claudin 18.2 Trial in Shanghai (cardonilizumab, LM-302)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • Shanghai, China
    Zhongshan hospital, Fudan University
Aug 12, 2023

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seongnam-si (nab-paclitaxel plus gemcitabine-cisplatin)

Recruiting
  • Biliary Tract Cancer
  • +2 more
  • nab-paclitaxel plus gemcitabine-cisplatin
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA Bundang Medical Center
Oct 27, 2022

Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

Recruiting
  • Advanced Biliary Tract Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022

Advanced Biliary Tract Cancer Trial in Taipei (Lenvatinib Pill,Paclitaxel)

Recruiting
  • Advanced Biliary Tract Cancer
  • Lenvatinib Pill,Paclitaxel
  • Taipei, Taiwan
    Taiwan Cooperative Oncology Group, National Health Research Inst
Jul 27, 2022

Biliary Tract Cancer Trial in Kaohsiung, Taichung (D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX)

Recruiting
  • Biliary Tract Cancer
  • D07001-softgel capsules + Xeloda (or TS-1)
  • mFOLFOX
  • Kaohsiung, Taiwan
  • +4 more
Dec 22, 2022

Biliary Tract Cancer Trial in Goyang-si, Seoul (SMT-NK inj.+Pembrolizumab, Pembrolizumab)

Recruiting
  • Biliary Tract Cancer
  • Goyang-si, Gyeonggi-do, Korea, Republic of
  • +2 more
Jun 28, 2022

Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)

Active, not recruiting
  • Biliary Tract Cancer
  • Ann Arbor, Michigan
  • +4 more
Oct 6, 2022

Advanced Biliary Tract Carcinoma Trial in Hangzhou (Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur)

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jul 6, 2022

Biliary Tract Adenocarcinoma Trial in Shanghai (HAIC, Gemcitabine, Oxaliplatin)

Enrolling by invitation
  • Biliary Tract Adenocarcinoma
  • HAIC
  • +4 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
May 27, 2022

Biliary Tract Cancer Trial (GEN-001, Pembrolizumab, mFOLFOX)

Not yet recruiting
  • Biliary Tract Cancer
  • (no location specified)
Aug 16, 2023

Biliary Carcinoma Trial in China (TQB3454 tablets, TQB3454 tablets matching )

Not yet recruiting
  • Biliary Carcinoma
  • TQB3454 tablets
  • TQB3454 tablets matching placebo
  • Beijing, Beijing, China
  • +5 more
Aug 4, 2023

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting
  • Biliary Tract Cancer
  • DNA Damage Repair Deficiency
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 8, 2022

Biliary Tract Cancer Trial in Montréal (Tumour and germline molecular profiling)

Recruiting
  • Biliary Tract Cancer
  • Tumour and germline molecular profiling
  • MontrĂ©al, Quebec, Canada
    McGill University Health Centre
Nov 2, 2022

Biliary Tract Tumors Trial (TST001)

Not yet recruiting
  • Biliary Tract Neoplasms
  • (no location specified)
Dec 28, 2021

Biliary Tract Cancer, PD-1 Antibody, Gemox Trial in Shanghai (PD-1+Lenvatinib+GEMOX)

Recruiting
  • Biliary Tract Cancer
  • +3 more
  • Shanghai, China
    Zhongshan hospital
Dec 11, 2021

Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • +3 more
  • Irinotecan Liposome Injection
  • +3 more
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Sep 16, 2021

Advanced Biliary Tract Cancer Trial in Taiwan (TS-1, Gemcitabine, Nivolumab)

Active, not recruiting
  • Advanced Biliary Tract Cancer
  • Kaohsiung, Taiwan
  • +5 more
Dec 7, 2021